期刊文献+

mTOR信号通路在卵巢型子宫内膜异位症中的表达及临床意义 被引量:2

Expression of mTOR signaling pathway in ovarian endometriosis and its clinical significance
在线阅读 下载PDF
导出
摘要 目的:探讨哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)信号通路蛋白在卵巢型子宫内膜异位组织中的表达及其临床意义。方法:利用RT—PCR、蛋白质免疫印迹法、免疫组织化学法检测2011年1月~2013年6月就诊我院的卵巢型子宫内膜异位症患者40例和正常增生期子宫内膜40例组织中mTOR及下游分子p70S6激酶(p70S6K)和4E—BP1的表达。结果:mTOR及下游分子p70S6K和4E—BP1在卵巢型子宫内膜异位组织中mRNA及蛋白的表达均低于正常子宫内膜组织。mTOR蛋白在卵巢型子宫内膜异位组织中为阳性表达,高于正常子宫内膜组织,且与痛经、月经异常、不孕无明显相关性,而与囊肿大小、异位内膜浸润深度及盆腔浸润情况关系显著。结论:mTOR信号通路与卵巢型子宫内膜异位症的发生、发展关系密切,mTOR蛋白失活可能是卵巢子宫内膜异位的显著标志,检测mTOR蛋白表达对卵巢子宫内膜异位的诊断具有一定意义。 Objective- To investigate the expression and clinical significance of mammalian target of rapamycin (mTOR) in ovarian endometriosis. Methods: The expression of mTOR and its downstream molecules pTOS6K and 4E-BP1 was detected by RT-PCR, western blot and immunohistochemical method in 40 ovarian endometriosis patients and in 40 normal hyperplasia endometrial issues in our hospital be- tween January 2011 and June 2013. Results: mRNA and protein expressions of mTOR and its downstream molecules pTOS6K and 4E-BP1 in ovarian endometriosis organization were higher than that in normal endo- metrium, mTOR protein was positively expressed in ovarian endometriosis, and was higher than in normal endometrium. The higher expression of mTOR in ovarian endometriosis was not related to dysmenorrhea, abnormal menstruation and barrenness, but to the size of cysts, the depth of ectopic intimal imbibition and the imbibition condition in pelvic cavity. Conclusion: mTOR signaling pathways is closely related to thedevelopment of ovarian endometriosis. Inactivation of mTOR may be a significant symbol of ovarian endo-metriosis, and mTOR protein expression is of certain significance in the diagnosis of ovarian endometrio- sis.
出处 《海南医学院学报》 CAS 2014年第7期884-887,共4页 Journal of Hainan Medical University
基金 深圳市宝安区科技计划项目(440430130004)~~
关键词 雷帕霉素靶蛋白(mTOR) P70S6K 4E—BP1 卵巢型子宫内膜异位症 mTOR p70S6K 4E-BP1 Ovarian endometriosis
作者简介 汪玉莲(1980-),女,本科,主治医师,电话:13420935813,电子信箱:szns120@126.com。
  • 相关文献

参考文献11

  • 1Parrales A, Lopez E, Lee-Rivera I, et al. ERK1/2-dependent activation of mTOR/mTORC1/p7OS6K regu- lates thrombin-induced RPE cell proliferation[J]. Cellular Signal ing,2013,25(4) .829-838.
  • 2侯桂琴,范天黎,王莉莉,陈秀英,王俊巍,薛乐勋.雷帕霉素对食管鳞癌裸鼠移植瘤生长及mTOR/p70S6K信号通路的影响[J].肿瘤,2009,29(6):559-562. 被引量:10
  • 3Heinonen H, Nieminen A, Saarela M, et al. Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer[J]. BMC Genomics, 2008,24 (9) :348.
  • 4Zhou Q, Deng Z, Zhu Y, et al. mTOR/p70S6K signal transduction pathway contributes to osteosarcoma progression and patients" prognosis[J]. Med Oncol, 2010, 27(4) :1239-1245.
  • 5Maj-Hes A, Medioni J, Scotte F, et al. Rechallenge with mTOR inhibitors in metastatic renal ce -ll carcino- ma patients who progressed on previous roTOR inhibi- tor therapy[J]. O ncology, 2013,85 ( 1 ) : 8-13.
  • 6Park JH, Kim JJ, Bae YS. Involvement of PI3K-AKT- roTOR pathway in protein kinase CK lI inhibition-mediated senescence in human colon cancer cells[J]. Biochem Biophys Res Commun,2013,433(4) :420-425.
  • 7Santulli P, Melonio I, Streuli I, et al. Increased serum CA125 levels in women with deeply infiltrating endometriosis[J]. Journal of Minimally Invasive Gynecology, 2013,20(6) :S27.
  • 8De Pradip, Miskimins K, Dey N, et al. Promise of rapalogues versus roTOR kinase inhibitors in subset specific breast cancer: Old targets new hope[J]. Cancer Treatment Reviews, 2013,39 (5) : 403-412.
  • 9Liu FY, Zhao ZJ, Li P, et al. Mammalian target of rapamyein (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck[J]. British Journal of Oral and Maxillofacial Surg -ery, 2010, 48(4) :291-296.
  • 10Motti ML,Califano D, Troncone G, et al. Complex regulation of the cyelin-dependent kinase inhibitor p27kipl in thyroid cancer cells by the PI3K/AKT path way: regulation of p27kipl expression and localization[J]. The American Journal of Pathology ,2005,166(3) .737- 749.

二级参考文献15

  • 1刘民锋,罗剑,余险峰,唐启彬,陈勇军,邹声泉.PTEN和mTOR信号转导通路在胆管癌发展中作用的研究[J].中国普通外科杂志,2006,15(4):274-276. 被引量:13
  • 2侯桂琴,刘明月,薛乐勋,鲁照明,范天黎,高媛,许培荣,刘兰琦.雷帕霉素对食管鳞癌细胞系EC9706的mTOR/p70S6K信号通路的影响[J].肿瘤,2007,27(3):172-175. 被引量:7
  • 3PENE F, CLAESSENE YE, MULLER O, et al. Role of the phosphatidylinositol 3-kinase/AKT and mTOR/p70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma[ J]. Oncogene, 2002, 21(43):6587-6597.
  • 4PANWALKER A,VERSTOVSEK S,GILES FJ. Mammalian target of rapamycin as therapy for hematologic malignancies[J]. Cancer, 2004,100(4) :657-666.
  • 5BJORNSTI MA, HOUGHTON PJ. The TOR pathway: a target for cancer therapy[ J]. Nat Rev Cancer, 2004, 4(5) :335-348.
  • 6ALBERT JM,KIM KW,CAO C, et al. Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer[J]. Mol Cancer Ther , 2006,5(5) :1183-1189.
  • 7GUBA M, BREITENBUCH PV, STEINBAUER M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis involvement of vascular endothelial growth factor[J]. Nat Med, 2002, 8(2) :128-13.5.
  • 8ASANO T, YAO Y, ZHU J, et al. The rapamycin anolog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation [ J ]. Biochem Biophys Res Commun, 2005, 331 ( 1 ) :295-302.
  • 9HOU G Q, XUE L X, LU Z M, et al. mTOR/p70S6K signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR [J]. Cancer Lett, 2007, 253 (2) :236-248.
  • 10ROWINSKY E K. Targeting the molecular target of rapamycin (mTOR) [J]. Curr Opin Oncol, 2004, 16(6) : 564-575.

共引文献45

同被引文献5

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部